Eri Toyoshima

662 total citations
15 papers, 500 citations indexed

About

Eri Toyoshima is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Eri Toyoshima has authored 15 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Eri Toyoshima's work include Cancer-related Molecular Pathways (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Photodynamic Therapy Research Studies (2 papers). Eri Toyoshima is often cited by papers focused on Cancer-related Molecular Pathways (4 papers), Lung Cancer Treatments and Mutations (3 papers) and Photodynamic Therapy Research Studies (2 papers). Eri Toyoshima collaborates with scholars based in Japan. Eri Toyoshima's co-authors include Yoshinobu Ohsaki, Kenjiro Kikuchi, S Fujiuchi, K Nakanishi, Shintaro Hirata, Naoyuki Miyokawa, Sachie Tanno, Y. Nishigaki, Yasuko Fujita and Satoshi Tanno and has published in prestigious journals such as BMC Cancer, Lung Cancer and International Journal of Oncology.

In The Last Decade

Eri Toyoshima

15 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eri Toyoshima Japan	8	330	236	220	73	46	15	500
Daniel P. Petro United States	11	243 0.7×	194 0.8×	188 0.9×	49 0.7×	54 1.2×	21	428
Maria S. Romero Spain	5	297 0.9×	266 1.1×	235 1.1×	56 0.8×	32 0.7×	6	497
Hiroaki Muguruma Japan	11	224 0.7×	154 0.7×	207 0.9×	47 0.6×	15 0.3×	15	408
Hidejiro Torigoe Japan	13	216 0.7×	186 0.8×	242 1.1×	108 1.5×	15 0.3×	28	450
Jorge D. Gallo United States	10	337 1.0×	127 0.5×	355 1.6×	75 1.0×	29 0.6×	23	558
Alberto Verlicchi Italy	12	268 0.8×	228 1.0×	175 0.8×	120 1.6×	37 0.8×	25	421
Özge Gümüşay Türkiye	11	164 0.5×	124 0.5×	100 0.5×	78 1.1×	33 0.7×	42	350
Konrad Klinghammer Germany	14	310 0.9×	181 0.8×	235 1.1×	125 1.7×	27 0.6×	53	580
Gillian Bethune Canada	8	222 0.7×	149 0.6×	189 0.9×	119 1.6×	44 1.0×	18	483
Carmelo Lupo Italy	11	176 0.5×	137 0.6×	150 0.7×	83 1.1×	32 0.7×	25	390

Countries citing papers authored by Eri Toyoshima

Since Specialization

Citations

This map shows the geographic impact of Eri Toyoshima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri Toyoshima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri Toyoshima more than expected).

Fields of papers citing papers by Eri Toyoshima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eri Toyoshima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri Toyoshima. The network helps show where Eri Toyoshima may publish in the future.

Co-authorship network of co-authors of Eri Toyoshima

This figure shows the co-authorship network connecting the top 25 collaborators of Eri Toyoshima. A scholar is included among the top collaborators of Eri Toyoshima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eri Toyoshima. Eri Toyoshima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Ohsaki, Yoshinobu, Takaaki Sasaki, Satoshi Endo, et al.. (2017). Observation of Zn-photoprotoporphyrin red Autofluorescence in human bronchial cancer using color-fluorescence endoscopy. BMC Cancer. 17(1). 289–289. 2 indexed citations

Watanabe, Kazue, et al.. (2016). Adverse Drug Reaction Following Quadrivalent Influenza Vaccination Coverage of Health Care Workers. Japanese Journal of Infection Prevention and Control. 31(6). 397–401. 4 indexed citations

Osanai, Shinobu, et al.. (2010). [Comparison between predicted equations obtained by standard Japanese values and present predicted equations for vital capacity and forced expiratory volume in one second].. PubMed. 48(5). 357–63. 4 indexed citations

Osanai, Shinobu, et al.. (2008). Renal Abscess with Morganella morganii Complicating Leukemoid Reaction. Internal Medicine. 47(1). 51–55. 6 indexed citations

Tanno, Sachie, Yoshinobu Ohsaki, K Nakanishi, Eri Toyoshima, & Kenjiro Kikuchi. (2004). Small cell lung cancer cells express EGFR and tyrosine phosphorylation of EGFR is inhibited by gefitinib (‘Iressa’, ZD1839). Oncology Reports. 12(5). 1053–7. 29 indexed citations

Tanno, Sachie, Yoshinobu Ohsaki, K Nakanishi, Eri Toyoshima, & Kenjiro Kikuchi. (2004). Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer. 46(1). 11–19. 103 indexed citations

Ohsaki, Yoshinobu, Sachie Tanno, Eri Toyoshima, et al.. (2001). Detection of Photofrin Fluorescence From Malignant and Premalignant Lesions in the Bronchus using a Full‐color Endoscopic Fluorescence Imaging System. Diagnostic and therapeutic endoscopy. 7(3-4). 187–195. 7 indexed citations

Toyoshima, Eri, Yoshinobu Ohsaki, Yutaka Nishigaki, et al.. (2001). Expression of syndecan-1 is common in human lung cancers independent of expression of epidermal growth factor receptor. Lung Cancer. 31(2-3). 193–202. 26 indexed citations

Nakanishi, K, et al.. (2000). Epidermal growth factor recepter expression correlates with poor prognosis in advanced non-small cell lung cancer patients with p53 overexpression. Lung Cancer. 29(1). 212–212. 10 indexed citations

10.

Ohsaki, Yoshinobu, Satoshi Tanno, Yasuko Fujita, et al.. (2000). Epidermal growth factor receptor expression correlates with poor prognosis in non-small cell lung cancer patients with p53 overexpression.. Oncology Reports. 7(3). 603–7. 217 indexed citations

11.

Yamaguchi, Satoshi, Yoshinobu Ohsaki, Y. Nishigaki, Eri Toyoshima, & Kenjiro Kikuchi. (1999). Inhibition of human small cell lung cancer cell growth by methylprednisolone.. International Journal of Oncology. 15(6). 1185–90. 4 indexed citations

12.

Nishigaki, Y., Yoshinobu Ohsaki, Eri Toyoshima, & Kenjiro Kikuchi. (1999). Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.. PubMed. 5(6). 1473–81. 18 indexed citations

13.

Kawamura, Yuichiro, et al.. (1998). A Case of Cardiac Sarcoidosis. Japanese Circulation Journal. 62(6). 458–461. 7 indexed citations

14.

Kimura, Takashi, Eri Toyoshima, Satoru Fujiuchi, et al.. (1996). [Respiratory disorders in type-1 hereditary motor and sensory neuropathy].. PubMed. 34(8). 850–5. 1 indexed citations

15.

Ohsaki, Yoshinobu, Eri Toyoshima, S Fujiuchi, et al.. (1996). bcl-2 and p53 protein expression in non-small cell lung cancers: Correlation with survival time. Lung Cancer. 16(1). 114–114. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact